Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Wave Life Sciences (WVE) Leases (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Leases for 11 consecutive years, with $11.0 million as the latest value for Q1 2026.

  • For Q1 2026, Leases fell 33.7% year-over-year to $11.0 million; the TTM value through Mar 2026 reached $11.0 million, down 33.7%, while the annual FY2025 figure was $12.5 million, 30.29% down from the prior year.
  • Leases hit $11.0 million in Q1 2026 for Wave Life Sciences, down from $12.5 million in the prior quarter.
  • Across five years, Leases topped out at $27.8 million in Q3 2022 and bottomed at $11.0 million in Q1 2026.
  • Average Leases over 5 years is $19.4 million, with a median of $19.1 million recorded in 2024.
  • Year-over-year, Leases surged 106.71% in 2023 and then plummeted 33.7% in 2026.
  • Wave Life Sciences' Leases stood at $26.8 million in 2022, then dropped by 15.67% to $22.6 million in 2023, then decreased by 21.06% to $17.9 million in 2024, then crashed by 30.29% to $12.5 million in 2025, then fell by 11.75% to $11.0 million in 2026.
  • According to Business Quant data, Leases over the past three periods came in at $11.0 million, $12.5 million, and $13.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.